Community Oncology Global Congress 2026

The Community Oncology Global Congress 2026 is an international virtual congress dedicated to advancing cancer care in community settings around the world. The event will bring together community oncologists, multidisciplinary cancer care professionals, healthcare leaders, researchers, patient advocates, and policymakers to discuss the real-world challenges and opportunities shaping oncology care beyond major academic centers.

Community oncology plays a critical role in cancer care delivery. For many patients, community-based oncology practices are the first and most important point of access to diagnosis, treatment, follow-up care, survivorship support, and palliative services. These settings are often where patients build long-term relationships with their care teams and where many practical decisions about cancer treatment are made.

The Community Oncology Global Congress 2026 will provide a platform for experts from different regions to share their experiences, highlight local and global barriers, and discuss strategies that can improve cancer outcomes for patients in their communities.

Registration is Open

Event Details

Date: August 28-30, 2026
Format: Virtual Congress
Live Streaming:  YouTube | X

About the Congress

The congress is designed to highlight the essential role of community oncology in improving access, quality, equity, and continuity of cancer care. Through expert-led sessions, regional perspectives, and multidisciplinary discussions, the program will explore how community-based cancer care can be strengthened across diverse healthcare environments.

The event will focus on practical topics that directly affect oncology professionals and patients, including access to timely diagnosis, treatment delivery, patient navigation, multidisciplinary collaboration, workforce development, survivorship care, palliative care, cancer prevention, and the use of digital tools in community oncology.

By bringing together experts from different countries and healthcare systems, the congress aims to encourage meaningful dialogue and support the development of adaptable solutions that can improve cancer care in community settings worldwide.

Scientific Program

The scientific program of the Community Oncology Global Congress 2026 will focus on the realities of delivering cancer care in community-based settings across the world. Sessions will feature expert presentations, panel discussions, regional experiences, and multidisciplinary conversations designed to address both shared global challenges and locally adapted solutions.

Community Oncology Global Congress Speaker

Images	Name
	Janet L. Abrahm Janet L. Abrahm Professor of Medicine, Harvard Medical School Pioneer in supportive and palliative oncology Founder, Palliative Care Service, Dana-Farber Cancer Institute and Brigham and Women’s Hospital Author of Comprehensive Guide to Supportive and Palliative Care for Cancer Patients.
	Katie Alexander Katie Alexander Adult-Gerontology Acute Care Nurse Practitioner specializing in adult oncology care Advanced Practice Provider Coordinator, American Oncology Network Oncology APP, Mark H. Zangmeister Cancer Center Focused on APP onboarding, education, and professional development.
	Alice Indini Alice Indini Medical Oncologist specializing in melanoma, cancer immunotherapy, and AYA oncology International melanoma researcher with over 100 peer-reviewed publications Focused on melanoma biology, immunotherapy response, survivorship care, and immune-related toxicities Involved in international oncology education, ESMO initiatives, and mentorship programs for young oncologists.
	Jeanine Frances Ewing Jeanine Frances Ewing Clinical Oncology Pharmacist, Florida Cancer Specialists Board Certified Oncology Pharmacist Specialist in oncology formulary management, evidence-based pharmacy practice, and multidisciplinary cancer care Speaker and consultant in oncology pharmacy education, guideline development, and clinical decision support.
	Korede Akindele Korede Akindele Chief Operating Officer, The Dorcas Cancer Foundation Global Child Health Leader, Health Systems Strategist, and Implementation Science Specialist Former Board Member, International Society of Paediatric Oncology Former Chair, Young SIOP Network Focused on childhood cancer control, early diagnosis, treatment access, survivorship, and health systems strengthening.
	Mohana Murali Kolluri Mohana Murali Kolluri Consultant Radiation Oncologist, Trinity Hospitals, Kakinada, India Specialist in advanced radiotherapy techniques, including IMRT, VMAT, IGRT, SBRT, and brachytherapy Focused on gastrointestinal and head and neck cancers, clinical research, cancer education, and evidence-based cancer awareness.
	Raghad Abdul Karim Raghad Abdul Karim Hematologist-Oncologist, NOVA Oncology Clinical researcher with contributions to over 60 clinical studies Focused on precision oncology, clinical trials, underserved communities, and patient-centered oncology care.
	Ruiling Yuan Ruiling Yuan Board-certified Medical Oncologist and Hematologist, Self Regional Healthcare Dyad Director, Cancer Service Line, Self Regional Healthcare Clinical Assistant Professor, Medical University of South Carolina Board Member, South Carolina Oncology Society Representative, ASCO State Affiliate Council and ASCO PAC Advisory Council Focused on community and rural cancer care, health policy, survivorship, patient access, and health literacy.
	Vinona Bhatia Vinona Bhatia Hematologist-Oncologist, Healthcare Operator, and Investor Founder, Partnering for Cancer Innovation Venture Partner, Cancer Fund Advisor and LP, How Women Invest and Coyote Ventures Focused on precision oncology, biomarker-driven care, health equity, clinical strategy, and cancer care innovation.
	Jenny Ahlstrom Jenny Ahlstrom Founder and CEO, HealthTree Foundation Multiple Myeloma Patient Advocate Focused on patient education, care navigation, research participation, and real-world data to accelerate better treatments and a cure.
	Christine Verinir Christine Verini Chief Executive Officer of CancerCare in the United States and a registered pharmacist and healthcare executive. She is a leader in oncology patient advocacy and cancer support services, with a focus on improving access to care, strengthening patient navigation, and advancing nonprofit healthcare leadership.
	Seema Harichand-Herdt Seema Harichand-Herdt Medical Oncologist and Hematologist, Mission Cancer + Blood Community Oncology Leader Focused on breast cancer care, clinical research, and patient-centered cancer care delivery.
	Lara Briseño Kenney Lara Briseño Kenney Medical Oncologist and Hematologist, United States Founder, Leeton Medical Leader in rural oncology, hematology, palliative care, and community-based cancer care Focused on expanding access to direct specialty care and improving cancer care delivery in underserved settings.
	Jahan Aghalar Jahan Aghalar Medical Oncologist and Hematologist, New York Cancer & Blood Specialists Leader in genitourinary oncology and community-based cancer care Focused on patient-centered hematology and oncology practice in the community setting.
	Reham Abdel-Wahab Reham Abdel-Wahab Medical Oncologist and Clinical Researcher, Cleveland Clinic Leader in clinical and translational cancer research Focused on cancer clinical trials, immuno-oncology, real-world data, and global oncology collaborations Dedicated to advancing evidence-based cancer care through innovative research and international partnerships.
	Fernando Maciel Barbosa Fernando Maciel Barbosa Medical Oncologist and Clinical Associate Professor, University of Iowa Health Care Specialist in genitourinary oncology, including prostate, bladder, and kidney cancers Focused on clinical research, cancer clinical trials, and equitable access to high-quality oncology care.
	Anjali Sibley Anjali Sibley Medical Oncologist and Hematologist, Stanford Medicine Cancer Center in Emeryville Clinical Associate Professor of Medicine, Stanford School of Medicine Director, Stanford Medicine Cancer Center in Emeryville Leader in community-based oncology Focused on cancer survivorship, health equity, clinical trial access, and patient-centered cancer care.
	Simon Blanc Simon Blanc Board-certified Hematologist and Medical Oncologist, South Florida Specialist in solid tumors and hematologic malignancies, including lung, breast, gastrointestinal cancers, leukemia, lymphoma, and myeloma Focused on advanced diagnostics, innovative therapies, and comprehensive multidisciplinary cancer care.
	Adil Iqbal Adil Iqbal Senior Consultant Surgical Oncology Expert in gastrointestinal, breast, and thoracic cancers Specialist in complex cancer surgery and patient-centered surgical care.
	Sergio Contreras Garduño Sergio Contreras Garduño Medical Oncologist, Mexico City, Mexico Specialist in solid tumors and hematologic malignancies Focused on evidence-based, patient-centered oncology and individualized treatment planning.
	Jose W. Avitia Jose W. Avitia Medical Oncologist and Hematologist, Albuquerque and Gallup, New Mexico Board-certified in Medical Oncology and Internal Medicine Focused on patient-centered cancer care in diverse and rural communities.
	Terri Conneran Terri Conneran Lung Cancer Survivor and Patient Advocate Advocate, KRAS Kickers Focused on KRAS-driven lung cancer awareness, education, community support, and research advocacy.
	Soham Banerjee Soham Banerjee Senior Consultant Genetic Counselor and Geneticist, Sharanya Super-Specialty Hospital Head, Department of Medical Genetics and Genetic Counseling, Sharanya Super-Specialty Hospital Senior Consultant, Bengal Cancer Foundation Hospital Specialist in cancer genetics, pediatric genetics, neurodevelopmental disorders, reproductive genetics, and infertility.
	Astriani Dwi Aryaningtyas Astriani Dwi Aryaningtyas Indonesian health advocate, psycho-oncology supporter, and cancer survivor. She is the founder of Inspirasien, a support platform that provides medical and psychological mentorship for patients and caregivers dealing with chronic and serious illnesses.
	Allen M. Chen Dr. Allen M. Chen Board-certified radiation oncologist and Chair of the Department of Radiation Oncology at the University of California, Irvine. He specializes in head and neck cancers and focuses on advanced radiation techniques, clinical trials, and improving cancer treatment outcomes. He has held academic leadership roles at major U.S. institutions and is known for his work in radiation oncology innovation and research.
	Joseph O. Adebayo Prof. Joseph O. Adebayo Professor of Biochemistry at the University of Ilorin, Nigeria. He holds B.Sc., M.Sc., and Ph.D. degrees in Biochemistry and specializes in clinical biochemistry, malaria research, and biochemical toxicology. He has published widely in peer-reviewed journals and received several awards and fellowships for his research, including TWAS-CNPq recognition. Prof. Adebayo has held multiple academic leadership roles and is actively involved in research supervision, grants, and international collaborations.
	Kurt R. Oettel Dr. Kurt R. Oettel Medical oncologist based in La Crosse, Wisconsin, affiliated with Gundersen Lutheran Medical Center and Black River Memorial Hospital. He earned his medical degree from the University of Wisconsin School of Medicine and Public Health and has over 20 years of clinical experience. He specializes in the diagnosis and treatment of cancers including lung, breast, and prostate cancer, using systemic therapies such as chemotherapy and comprehensive oncology care.
	Astha Thakkar Astha Thakkar Board-certified Hematologist-Oncologist Specialist in leukemia, lymphoma, and multiple myeloma Focused on patient-centered care and individualized treatment planning.
	Kashif Ali Kashif Ali Board-certified Medical Oncologist and Hematologist, Maryland Oncology Hematology Specialist in gastrointestinal and pancreatic malignancies Focused on comprehensive inpatient and outpatient cancer care.

The program will explore how community oncology teams can improve care coordination, strengthen patient-centered treatment, reduce disparities, and expand access to high-quality cancer care outside major academic centers.

Who Should Attend

This congress is designed for community oncologists, medical oncologists, hematologists, radiation oncologists, surgical oncologists, oncology nurses, oncology pharmacists, palliative care professionals, patient advocates, healthcare administrators, researchers, policymakers, representatives of cancer organizations, and all professionals involved in improving cancer care delivery in community settings.

Why Attend

The Community Oncology Global Congress 2026 will provide a platform for international experts and frontline oncology professionals to discuss how cancer care is delivered outside major academic centers and how community-based care can be strengthened.

Participants will gain practical insights from diverse regions, learn from real-world experiences, and join a global conversation focused on improving access, quality, equity, and outcomes for patients with cancer.